Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: A cohort study
Jorge I. Salluh(Universidade Federal do Rio de Janeiro), Pedro Póvoa(University of Lisbon), José Roberto Lapa e Silva(Universidade Federal do Rio de Janeiro), Patrı́cia T. Bozza(Fundação Oswaldo Cruz), Hugo C. Castro‐Faria‐Neto(Fundação Oswaldo Cruz), Luís Coelho(University of Lisbon), Márcio Soares(University of Copenhagen), Fernando A. Bozza(D’Or Institute for Research and Education), Juan Carlos Rosso Verdeal(D’Or Institute for Research and Education)
Cited by 51
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Lipid droplets: platforms with multiple functions in cancer hallmarks
|Cell Death and Disease|2020|530
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|The Lancet Respiratory Medicine|2021|527